N.E.W. Advisory Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
N.E.W. Advisory Services's ABBV Position: Q2 2026 in Review
N.E.W. Advisory Services reduced its AbbVie (ABBV) stake by 1.8% in Q2 2026, selling an estimated $11K and leaving 2,820 shares worth $710K. The position accounts for 0.05% of the portfolio, ranked #126.
N.E.W. Advisory Services first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $733K in Q1 2025. 2,739 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- N.E.W. Advisory Services held 2,820 shares of AbbVie worth $710K as of Q2 2026.
- N.E.W. Advisory Services sold 51 AbbVie shares in Q2 2026, an estimated $11K.
- AbbVie made up 0.05% of N.E.W. Advisory Services's portfolio in Q2 2026, its #126 holding.
- N.E.W. Advisory Services first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
- N.E.W. Advisory Services's AbbVie position peaked at $733K in Q1 2025.
- 2,739 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on N.E.W. Advisory Services's 13F filing for Q2 2026, filed 6 Aug 2026.